Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials - Khan, A; Faucett, J; Morrison, S (JAMA Psychiatry, 2013)